Literature DB >> 16611869

Treatment of ankylosing spondylitis with pamidronate: an open label study.

R Grover, S Shankar, R Aneja, V Marwaha, R Gupta, A Kumar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16611869      PMCID： PMC1798153          DOI： 10.1136/ard.2005.041392

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  Bisphosphonates--targeting bone in the treatment of spondyloarthritis.

Authors:  H Haibel; J Braun; W P Maksymowych
Journal:  Clin Exp Rheumatol       Date:  2002 Nov-Dec       Impact factor: 4.473

2.  Treatment of active ankylosing spondylitis with pamidronate.

Authors:  H Haibel; J Brandt; M Rudwaleit; H Soerensen; J Sieper; J Braun
Journal:  Rheumatology (Oxford)       Date:  2003-08       Impact factor: 7.580

3.  An open study of pulse pamidronate treatment in severe ankylosing spondylitis, and its effect on biochemical markers of bone turnover.

Authors:  A P Cairns; S A Wright; A J Taggart; S M Coward; G D Wright
Journal:  Ann Rheum Dis       Date:  2004-04-19       Impact factor: 19.103

4.  An open study of pamidronate in the treatment of refractory ankylosing spondylitis.

Authors:  W P Maksymowych; G S Jhangri; S Leclercq; K Skeith; A Yan; A S Russell
Journal:  J Rheumatol       Date:  1998-04       Impact factor: 4.666

5.  Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Authors:  S van der Linden; H A Valkenburg; A Cats
Journal:  Arthritis Rheum       Date:  1984-04

6.  Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate.

Authors:  Glen S Markowitz; Gerald B Appel; Paul L Fine; Andrew Z Fenves; Nicholas R Loon; Sundar Jagannath; Joseph A Kuhn; Adam D Dratch; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2001-06       Impact factor: 10.121

7.  Clinical and radiological amelioration of refractory peripheral spondyloarthritis by pulse intravenous pamidronate therapy.

Authors:  W P Maksymowych; R Lambert; G S Jhangri; S Leclercq; P Chiu; B Wong; S Aaron; A S Russell
Journal:  J Rheumatol       Date:  2001-01       Impact factor: 4.666

8.  Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.

Authors:  J J Anderson; G Baron; D van der Heijde; D T Felson; M Dougados
Journal:  Arthritis Rheum       Date:  2001-08

9.  A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.

Authors:  Walter P Maksymowych; Gian S Jhangri; Avril A Fitzgerald; Sharon LeClercq; Peter Chiu; Alex Yan; Kenneth J Skeith; Stephen L Aaron; Joanne Homik; Paul Davis; Dale Sholter; Anthony S Russell
Journal:  Arthritis Rheum       Date:  2002-03

10.  Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis.

Authors:  J Brandt; J Listing; J Sieper; M Rudwaleit; D van der Heijde; J Braun
Journal:  Ann Rheum Dis       Date:  2004-03-25       Impact factor: 19.103
  10 in total
  6 in total

Review 1.  Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.

Authors:  Nurullah Akkoc; Gercek Can; Salvatore D'Angelo; Angela Padula; Ignazio Olivieri
Journal:  Curr Rheumatol Rep       Date:  2017-02       Impact factor: 4.592

Review 2.  A systematic MEDLINE analysis of therapeutic approaches in ankylosing spondylitis.

Authors:  L Goh; A Samanta
Journal:  Rheumatol Int       Date:  2009-06-28       Impact factor: 2.631

Review 3.  Pamidronate treatment in rheumatology practice: a comprehensive review.

Authors:  Gleb Slobodin; Itzhak Rosner; Joy Feld; Doron Rimar; Michael Rozenbaum; Nina Boulman; Majed Odeh
Journal:  Clin Rheumatol       Date:  2009-08-19       Impact factor: 2.980

4.  Intravenous pamidronate for refractory rheumatoid arthritis.

Authors:  Mansour Salesi; Peyman Mottaghi; Mansour Karimifar; Ziba Farajzadegan
Journal:  J Res Med Sci       Date:  2012-05       Impact factor: 1.852

Review 5.  Rheumatology science and practice in India.

Authors:  Durga Prasanna Misra; Aman Sharma; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2018-07-19       Impact factor: 3.580

6.  Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis.

Authors:  Suzanne Arends; Freke Wink; Joyce Veneberg; Reinhard Bos; Eric van Roon; Eveline van der Veer; Fiona Maas; Anneke Spoorenberg
Journal:  Br J Clin Pharmacol       Date:  2020-07-05       Impact factor: 3.716
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.